Gonadotropins stimulate gonadal cell steroid secretion primarily through activation of a cAMP-protein kinase A signal transduction pathway. Various growth factors have been shown to inhibit gonadotropin-stimulated steroidogenesis, however, the intracellular signaling cascades involved in growth factor inhibition have not been characterized. The present study investigated whether Src tyrosine kinase, a nonreceptor tyrosine kinase activated in response to growth factor stimulation and previously shown to inhibit LH-stimulated progesterone secretion, acts via activation of Ras stimulated pathways, phosphatidylinositol-3-kinase (PI3-kinase) stimulated pathways, or both in MA10 Leydig cells. Direct activation of Src in MA10 cells that express a temperature sensitive Src was associated with an increase in GTP-bound Ras, indicating increased Ras activity in response to Src activation. Direct activation of Ras by way of expression of a constitutively active Ras (Ras؉) was associated with a decrease in LH responsiveness. Coexpression of a dominant negative Src, which by itself increases LH responsiveness in MA10 cells, had no effect on Ras؉ inhibition on LH responsiveness, further demonstrating that Src is upstream of Ras. In addition, MA10 Ras؉ cells were relatively unresponsive to cholera toxin or 8-bromo cAMP, indicating the effects of Ras are independent of cAMP generation. Wortmannin, a PI3-kinase inhibitor, did not restore LH responsiveness to cells expressing activated Src or constitutively active Ras. These results demonstrate that Src activates a Ras pathway in MA10 Leydig cells, and that activation of Ras is associated with a loss of LH responsiveness that is independent of PI3-kinase.
INTRODUCTION
Gonadotropic hormones stimulate gonadal steroidogenic cells to synthesize and secrete sex steroid hormones. Both LH and FSH bind specifically to their respective seven transmembrane-spanning G-protein coupled receptors (LH-R and FSH-R). Both the LH-R and FSH-R are primarily coupled to G s␣ which, upon activation, stimulates adenylate cyclase, leading to increased intracellular cAMP and activation of cAMP-dependent protein kinase A, with the end result of increased steroidogenesis and steroid secretion. Many studies have demonstrated that growth factors such as epidermal growth factor [1, 2] , platelet-derived growth factor [3, 4] , and the fibroblast growth factors [5] modulate gonadotropin-stimulated steroid secretion by gonadal steroidogenic cells, however, the mechanisms by 1 Supported by grant HD-36013 from the National Institutes of Health. Previous reports demonstrated that herbimycin A, a specific inhibitor of the Src family of nonreceptor tyrosine kinases, potentiated LH-stimulated progesterone secretion by rat thecal-interstitial cells [6] . Herbimycin was found to indirectly inhibit cAMP-specific phosphodiesterase activity, thus increasing LH-stimulated cAMP accumulation [6, 7] . Furthermore, it was found that expression of a dominant negative Src tyrosine kinase in MA10 Leydig cells was associated with an increase in LH responsiveness and a decrease in phosphodiesterase activity, whereas expression of a temperature sensitive Src was associated with a decrease in LH responsiveness at the Src active temperature [8] . Thus it appears that Src tyrosine kinase activity modulates LH-stimulated progesterone secretion, at least in part by modulation of phosphodiesterase activity. However, it is also likely that Src is involved in activating growth factor signaling cascades that may also affect the cAMP-protein kinase A pathway activated by LH.
In many cell types, Src is known to activate phosphatidylinositol-3-kinase (PI3-kinase), a ubiquitous kinase that phosphorylates phosphoinositides at the D-3 position of the inositol ring [9] . Phosphatidylinositol-3,4,5-triphosphate, the most abundant metabolite of PI3-kinase activity, is a potent stimulator of PKC [10] , a ubiquitous [11] Ca 2ϩ -independent, diacylglycerol-insensitive protein kinase C isoform [12] . However, Src is also believed to act through Ras [13] , and there is evidence to suggest that activation of PI3-kinase is via a Ras-dependent mechanism [14] . Conversely, activation of Ras in some systems appears to be downstream of PI3-kinase [15] , with Ras directly activating PKC [16] .
The present studies were undertaken in order to determine whether Src might be acting via a Ras pathway, a PI3-kinase pathway, or both. Cell lines expressing either a dominant negative Src or a temperature sensitive Src tyrosine kinase that have been previously described [8] were utilized. In addition, new lines expressing a constitutively active Ras with or without a dominant negative Src kinase were created. The results indicate that Src activates Ras and that Ras activation is associated with lower progesterone secretion in response to LH stimulation. The loss of LH responsiveness is independent of PI3-kinase.
MATERIALS AND METHODS

Reagents
All liquid media, G418 sulfate, and lipofectamine were purchased from Life Technologies (Grand Island, NY). A panspecific Ras antibody (clone Y13-259) and protein AGϩ agarose were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). An Src-specific antibody (clone 327) was purchased from Oncogene Science (Cambridge, MA). Antibodies specific for phospho-Akt and total Akt were purchased from Cell Signaling Technology (Beverly, MA). A Ras activation assay kit was from Upstate Biotechnology (Lake Placid, NY). Ovine LH (LH S-25; 2.3 U/mg) was obtained from the National Hormone and Pituitary Program (Bethesda, MD). Wortmannin was obtained from Calbiochem (La Jolla, CA).
[ 32 P]Orthophosphate (500 mCi/ml) was obtained from ICN (Costa Mesa, CA). Enhanced chemiluminescence Western blotting detection reagents were purchased from Amersham Life Science (Arlington Heights, IL). All other reagents were purchased from Sigma (St. Louis, MO).
Constructs
A modified pSG5 vector containing a sequence encoding a dominant negative Src kinase (Srck Ϫ ) under the control of the simian SV40 promoter was generously provided by Sara Courtneidge (The Van Andel Research Institute, Grand Rapids, MI). The kinase inactivating mutation was Lys 295 → Met [17] . A pLNCX plasmid containing a G418 resistance gene and a sequence encoding a temperature sensitive Src kinase (tsUP) under the control of the Maloney murine leukemia virus promoter was kindly provided by Joan Brugge (Harvard University, Cambridge, MA). A mutation of Glu 280 → Lys results in a viral Src protein that is active at 35ЊC and inactive at 39.5ЊC [18] . A pSVras construct encoding the oncogenic valine 12 mutant Ha-ras under the control of the SV40 early promoter was provided by Arthur Gutierrez-Hartmann (University of Colorado Health Sciences Center, Denver, CO). A pSV2neo plasmid to convey G418 resistance was generously provided by Michael Soares (University of Kansas Medical Center, Kansas City, KS).
Cell Lines
MA10 Leydig tumor cells were originally provided by Mario Ascoli (University of Iowa, Iowa City, IA). The MA10 pSV2neo , MA10 Srck-2 and MA10 SrctsUP cell lines were produced as previously described [8] . Cells were cultured in Dulbecco modified Eagle medium (DMEM)/Ham F12 1: 1, 15 mM Hepes, 5% horse serum, 2.5% fetal bovine serum, and 200 g/ ml of G418 sulfate. All cell lines were routinely maintained at 37ЊC in a water-saturated atmosphere of 95% air and 5% CO 2 , except for MA10 SrctsUP cells, which were maintained at 39.5ЊC, the temperature sensitive Src inactive temperature.
MA10 Rasϩ and MA10 Src-Rasϩ cells were produced by cotransfecting MA10 Leydig cells with pSVras and pSV2neo (MA10 Rasϩ cells) and pSG5srckϪ, pSVras and pSV2neo (MA10 Src-Rasϩ cells) using lipofectamine according to the protocol of the manufacturer (Life Technologies). Briefly, MA10 cells were plated at 2-4 ϫ 10 5 cells/ml in serum containing medium (without G418) as described above. The following day, cells were washed two times with serum-free, antibiotic-free media. Media were removed and replaced with 1 ml of serum-free, antibiotic-free media containing lipofectamine and DNA complexes (1.0 g of pSVras and 0.1 g of pSV2neo, or 1.0 g of pSG5srckϪ, 1.0 g of pSVras, and 0.15 g pSV2neo) and allowed to incubate for 5 h. After 5 h, 1 ml of medium plus serum was added to each well. Following 72 h of incubation, media were changed to fresh serum containing media plus 200 g/ml of G418 sulfate. Over the next several weeks, G418-resistant clones were selected and characterized for Ras and Src expression. All clones were maintained in media containing G418 sulfate.
To determine progesterone secretion, cell lines were plated in tissue culture plates (20 000 cells/cm 2 ) in serum containing DMEM/Ham F12 media. Cells were allowed to attach and grow for approximately 32 h, and then media were changed to fresh serum-free, antibiotic-free media. Sixteen hours later, cells were rinsed and fresh serum-free, antibiotic-free media were added. Cells were then challenged with ovine LH (oLH NIH-25; 50 ng/ml), 8 bromo-cAMP (1 mM), cholera toxin (500 ng/ml), or vehicle (1% PBS in media) as specified in Results. When the kinase inhibitor wortmannin was used, cells were preincubated with wortmannin (10-100 nM) or vehicle (0.5% DMSO) for 16 h before stimulation with LH. Wortmannin or vehicle remained in the media during the LH stimulation period. At the end of the LH stimulation period, media were collected for progesterone determination by radioimmunoassay as previously described [19] . Intraassay and interassay coefficients of variation were 6% and 11%, respectively. The limit of detection was 0.25 ng/ml.
Determination of Ras Activity
The ratio GDP-bound:GTP-bound Ras was used to determine cellular Ras activity [20] . Cells were plated in T75 flasks and allowed to grow until they were approximately 75% confluent. Cells were then serum starved for 16 h, labeled with [ 32 P]orthophosphate (0.5 mCi/ml for 4 h) in phosphate-free media, and subsequently lysed in RIPA buffer (50 mM Tris-HCl pH 7.4, 1% NP40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EGTA, 1 mM PMSF, 1 mM sodium orthovanadate, 1 mM sodium fluoride, 1 g/ml aprotinin, and 1 g/ml leupeptin). Cellular lysates were cleared of insoluble material by centrifugation (14 000 ϫ g for 20 min). Anti-Ras antibody (1 g) was added to the total soluble lysate and incubated at 4ЊC for 2 h with constant agitation. Protein AG ϩ agarose (20 l) was then added, and the lysates were further incubated overnight at 4ЊC with constant agitation. Immunoprecipitates were collected by centrifugation (14 000 ϫ g for 2 min at 4ЊC), washed extensively, and resuspended in 20 l of 20 mM Tris-HCl pH 7.5, 20 mM EDTA, 2% SDS, 0.5 mM GDP, and 0.5 mM GTP. Ras-bound guanine nucleotides were eluted by heating to 65ЊC for 5 min and centrifuging at 14 000 ϫ g for 5 min. The eluted guanine nucleotides were then separated by spotting 5 l of supernatant on polyethyleneimine cellulose thin layer chromatography (TLC) plates and developing with 0.75 M KH 2 PO 4 (pH 3.4). Following autoradiography of the TLC plates, GDP and GTP spots were isolated from the plates and quantified by liquid scintillation counting. The percentage of GTP-bound Ras was calculated by GTP cpm /[(GDP cpm ϫ 1.5) ϩ GTP cpm ].
Nonradioactive Ras activation assays utilizing a Raf-1-GST-agarose conjugate fusion protein containing the Ras binding domain of Raf-1, and which binds only activated GTP-bound Ras, were also performed. At the end of the treatment period, cells were lysed in Ras lysis buffer (25 mM Hepes pH 7.5, 150 mM NaCl, 1% NP-40, 100 mM MgCl 2 , 1 mM EDTA, 2% glycerol, 1 mM PMSF, and 1 mM sodium orthovanadate). Cellular protein (500 g) was mixed with 5 l of a Raf-1-GST-agarose conjugate fusion protein containing the Ras binding domain of Raf-1, and which binds only activated GTP-bound Ras. The mixture was allowed to incubate overnight at 4ЊC with gentle agitation. Agarose beads were collected and washed three times with lysis buffer. Agarose beads were then resuspended
FIG. 6. Wortmannin does not restore progesterone secretion in MA10
Leydig cells with activated Ras. Control MA10 cells (Neo) and MA10 cell lines expressing a constitutively active Ras (Ras ϩ1 and Ras ϩ2 ) were cultured at 37ЊC. Cells were serum starved and pretreated with the PI3-kinase inhibitor wortmannin for 16 h, and then stimulated with ovine LH (50 ng/ ml) for 2 h. Cells were collected and lysed, and lysates were analyzed by immunoblot analysis for phosphorylated Akt and total Akt expression (a). In separate experiments, media were collected and analyzed for progesterone by specific radioimmunoassay (b). Data represent means Ϯ SEM of three replicates within a representative experiment (b). Experiments were repeated a minimum of three times with qualitatively similar results.
in 2ϫ Laemmli sample buffer, heated to 95ЊC for 5 min, and centrifuged at 14 000 ϫ g. The supernatant was then subjected to SDS-PAGE (12% gel) and immunoblot analysis as described above with an antibody specific for Ras.
Statistical Analysis
Unless otherwise specified, the results are presented as means Ϯ standard errors (SEM) from representative experiments. Three replicates per treatment were used for each experiment. For statistical analysis, means across treatments were subjected to an analysis of variance with differences between individual means compared by a Fisher protected least significant differences test (Statview 512ϩ, Agoura Hills, CA). Experiments were repeated a minimum of three times in order to determine relative consistency of results.
RESULTS
Activation of Src Leads to Increased Ras Activity
In order to determine whether Src activates Ras, MA10 pSV2neo cells (control cells) and MA10 Src-tsUP cells were cultured at 39.5ЊC (the temperature sensitive Src inactive temperature), 39.5ЊC then shifted to 35ЊC (the Src active temperature) for 1 h, or they were maintained at 35ЊC. The percentage of GTP-bound Ras in MA10 pSV2neo cells was relatively low (approximately 5%), indicating a low level of Ras activity, and was unaffected by the culture temperature (Fig. 1) . MA10 Src-tsUP cells cultured at 39.5ЊC also had relatively low levels of GTP-bound Ras, however, shifting MA10 Src-tsUP cells to 35ЊC for 1 h was associated with a doubling of GTP-bound Ras, indicating Ras activation. Maintaining MA10 Src-tsUP cells at 35ЊC was associated with an even greater increase in the proportion of GTP-bound Ras (approximately 20%). As confirmation, a second type of Ras activation assay was employed. GTPbound Ras was precipitated with a fusion protein containing the Ras binding domain of Raf-1, which binds only activated GTP-bound Ras. Again, temperature had no effect on the proportion of precipitated GTP-bound Ras in MA10 pSV2neo cells. In contrast, precipitated GTP-bound Ras increased in MA10 Src-tsUP cells that were shifted to 35ЊC for 1 h or maintained at 35ЊC compared with MA10 Src-tsUP cells maintained at 39.5ЊC. These results demonstrate that Src can activate Ras in MA10 cells.
Ras Activation Inhibits LH-Stimulated Progesterone Secretion
It was previously demonstrated that inhibition of Src in thecal-interstitial cells and MA10 Leydig cells was associated with a higher responsiveness to LH stimulation with regard to cAMP and progesterone secretion, whereas activation of Src was associated with a loss of responsiveness [8] . In order to determine whether Ras is involved in this loss of responsiveness, MA10 Leydig cell lines expressing a constitutively active Ras (MA10 Rasϩ ) and cells coexpressing a dominant negative Src and a constitutively active Ras (MA10 Src-Rasϩ ) were created. Immunoprecipitation and immunoblot analysis with an antibody specific for Src demonstrates high expression of Src protein in MA10 Src-Rasϩ compared to MA10 pSV2Neo control cells and MA10 Rasϩ cells, indicating expression of the Src dominant negative (Fig. 2a) . Two clonal lines of each MA10 Rasϩ and MA10 SrcRasϩ cells show greatly elevated proportions of GTP-bound Ras, indicating expression of the constitutively active Ras (Fig. 2, b and c ; results from only one cell line shown). Coexpression of the dominant negative Src had no effect on the proportion of GTP-bound Ras in cells expressing the constitutively active Ras (MA10 Src-Rasϩ cells; Fig. 2) .
As previously reported, MA10 Srck-2 cells have an even greater response to LH stimulation than the MA10 pSV2neo control cells (Fig. 3) . Conversely, MA10 Rasϩ cells show a large attenuation of LH-stimulated progesterone secretion, thus demonstrating that direct activation of Ras is associated with a loss of LH responsiveness. Furthermore, coexpression of the Src dominant negative in MA10 Src-Rasϩ cells did not rescue or reverse the effects of expression of the constitutively active Ras, providing further support for our observation that Src is upstream of Ras.
In order to determine whether the effects of Ras activation were on cAMP generation, MA10 pSV2neo and MA10 Rasϩ cells were stimulated with either cholera toxin or 8-bromo cAMP. MA10 Rasϩ cells again had an attenuated response to both cholera toxin and 8-bromo cAMP compared to the MA10 pSV2neo control cells (Fig. 4) , indicating the effects of Ras activation are distal to or independent of cAMP generation.
Wortmannin Does Not Rescue MA10 Cells from Src or Ras Activation
Src activation is often associated with activation of PI3-kinase, which may or may not be via Ras. Our various cell lines were treated with the PI3-kinase inhibitor wortmannin (16 h of pretreatment) in order to determine whether PI3-kinase was involved in the Src/Ras desensitization of MA10 Leydig cells to LH stimulation. As expected, culture of MA10 Src-tsUP cells at the Src active temperature inhibited LH-stimulated progesterone secretion compared to MA10 pSV2neo control cells cultured at the same temperature (Fig. 5) . MA10 Src-tsUP cells pretreated with wortmannin (100 nM) remained relatively unresponsive to LH stimulation, indicating that PI3-kinase is not involved in the Src induced loss of LH responsiveness. Similarly, wortmannin (10 to 100 nM) was unable to reverse the effects of Ras activation in MA10 Rasϩ cells (Fig. 6) . Importantly, wortmannin (50-100 nM) completely inhibited Akt phosphorylation, demonstrating inhibition of PI3-kinase activity (Fig. 6 ). Results were further confirmed with a second PI3-kinase inhibitor, LY294002 (data not shown).
DISCUSSION
Numerous reports have demonstrated that treatment of gonadal steroidogenic cells with growth factors such as epidermal growth factor (EGF), platelet-derived growth factors (PDGFs), and fibroblast growth factor results in an attenuation of gonadotropin-stimulated steroid secretion [1] [2] [3] [4] [5] . The mechanisms by which growth factor stimulation modulates steroidogenesis have yet to be fully elucidated. Many receptor tyrosine kinases, such as the EGF receptor, signal at least partially through the activation of the small G protein, Ras. Results from the present study indicate that Src tyrosine kinase, an intracellular kinase activated by numerous growth factor receptors, can activate Ras in MA10 Leydig cells. In addition, the present study demonstrates for the first time that direct activation of Ras by way of expression of a constitutively activated Ras is associated with a loss of responsiveness to LH stimulation.
These findings confirm and extend our previous reports that activation of Src inhibits LH-stimulated progesterone secretion [8] , whereas inhibition of Src potentiates LH stimulation [6, 8] . They also suggest that growth factors that activate Ras can inhibit LH-stimulated progesterone secretion independent of cAMP generation. Treatment of MA10 Rasϩ and MA10 Src-Rasϩ cells were relatively unresponsive to either cholera toxin or 8-bromo cyclic AMP. This is somewhat at odds with a previous report that EGF-induced desensitization of MA10 cells was completely accounted for by a decrease in LH receptor number and that EGF pretreated cells were fully responsive to cholera toxin and 8-bromo cAMP [2] . However, that report also demonstrated that the EGF receptor was rapidly internalized, perhaps terminating the EGF signal, whereas LH receptor down-regulation and replenishment lagged far behind. The present work utilized a constitutively active Ras, resulting in a constitutively activated growth signaling pathway. It is interesting that MA10 Rasϩ cells could be further desensitized with LH pretreatment, but EGF pretreatment did not result in further desensitization (unpublished observations). A recent report demonstrates that inhibition of mitogen-activated protein kinase kinase (MEK), a downstream effector of Ras, is associated with increased gonadotropin-stimulated steroidogenesis. This appears to be the result of increased intracellular steroidogenic acute regulator protein (StAR) content [21] .
As demonstrated in the present study, direct activation of Src can lead to activation of Ras. However, whether Src is required for growth factor activation of Ras is uncertain. Src is believed to phosphorylate secondary tyrosine sites within the cytoplasmic tail of growth factor receptors such as PDGF-R␤ [22] . A previous study utilizing primary cultures of porcine thecal cells reported that herbimycin A, an Src selective inhibitor, blocked PDGF receptor activation [4] and thus Ras activation. However, it was not clear whether the effects of herbimycin A were direct effects on the receptor or through inhibition of Src, blocking secondary PDGF receptor tyrosine phosphorylation.
A common consequence of Src-Ras activation is the activation of PI3-kinase. Wortmannin, a PI3-kinase inhibitor, did not revert MA10 cells in which Src or Ras had been activated, to a more LH responsive phenotype, suggesting that PI3-kinase activation is not important in the Src-Ras induced loss of LH responsiveness. Akt phosphorylation is a measure of PI3-kinase activity. Wortmannin treatment inhibited Akt phosphorylation in a dose-dependent manner, demonstrating PI3-kinase inhibition by wortmannin. These findings are in accordance with previous reports that wortmannin has no effect on steroidogenesis in porcine thecal cells treated with PDGF-BB and LH [4] .
How activation of a Src-Ras pathway is inhibiting steroidogenesis is not clear but is probably via multiple mechanisms, both before and after cAMP generation. Various studies have demonstrated that growth factor stimulation decreases LH-receptor content [1, 2] and steroidogenic enzyme expression [2, 23] . There is also evidence that activation of MEK and extracellular-regulated kinase, downstream effectors of Ras activation, are associated with a decrease in StAR protein [21] . At another level, activation of Src and Ras may be important for G-protein deactivation. Although the evidence is still limited, there is speculation that regulators of G-protein signaling are activated by Ras or Ras-associated proteins [24, 25] . In addition, Src has been shown to phosphorylate G protein-coupled receptor kinase 2 (GRK2), ultimately deactivating the G protein signal [26] . Finally, G protein-coupled receptors, including LH receptors, are internalized by an arrestin-dependent mechanism [27] [28] [29] . Src appears to be necessary for this arrestin-dynamin mediated G protein-coupled receptor desensitization [30, 31] . Thus, constitutive activation of Src may be associated with ligand-independent LH receptor desensitization.
In conclusion, activation of Src tyrosine kinase in MA10 Leydig cells is associated with Ras activation. This in turn desensitizes MA10 cells to LH stimulation with regard to steroid secretion. This desensitization is independent of PI3-kinase activation.
